Inflammation

Matrix metalloproteinase 2 may be associated with the progression of chronic kidney disease, especially in patients with low inflammation or with proteinuria, data show.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Victor Perlroth, MD, CEO of Kodiak Sciences, provides an overview of the company’s ongoing retinal therapy programs.

KIAWAH ISLAND, S.C. — Drug-eluting implants in various stages of study and approval may provide efficient, sustained drug delivery, overcoming barriers to penetration, according to a speaker at Kiawah Eye.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Dilsher S. Dhoot, MD, of California Retina Consultants, discusses positive 40-week data from the phase 1 HELIOS trial.

SAN DIEGO —– New daily persistent headache presents itself relatively early in life, is commonly triggered by stress and leads to stigma and disability, according to a speaker at the American Headache Society Annual Scientific Meeting.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Patricio Schlottmann, MD, discusses dual inhibition of the Ang-2 and VEGF pathways.

Hormone replacement therapy may render the skin of postmenopausal women both more prone to inflammation and more capable of repairing itself, according to a study.

PHILADELPHIA — In patients with acute MI who had successful PCI and underwent imaging to assess plaque composition, diabetes raised risk for poor outcomes but the difference was not related to plaque, according to a presentation.

PHILADELPHIA — In this Healio video exclusive, Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, presents updated multispecialty practice recommendations for diabetes, cardiorenal and metabolic diseases at the Heart in Diabetes CME Conference.

Researchers found a significant association between type 2 inflammation and asthma and an increased risk for coronary artery disease.